| Annual EBITDA (Millions of US $) |
|---|
| Quarterly EBITDA (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| $0.000B | $0.000B | ||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| XBP Europe Holdings (XBP) | United States | $0.196B | 0.00 |
| Spyre Therapeutics (SYRE) | United States | $0.079B | 0.00 |
